Antibodies specifically binding to zika virus epitopes and uses thereof
US11117954B2 · kind B2 · utility
1Cited by
12References
31Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 12, 2017 |
| Grant date | Sep 14, 2021 |
| Priority date | — |
| Expiry date | Jul 12, 2037 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to antibodies, and antigen binding fragments thereof, that potently neutralize infection of ZIKV. The invention also relates to antigenic sites to which the antibodies and antigen binding fragments bind, as well as to nucleic acids that encode and immortalized B cells that produce such antibodies and antibody fragments. In addition, the invention relates to the use of the antibodies and antibody fragments of the invention in screening methods as well as in the diagnosis, prophylaxis and treatment of ZIKV infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.